Literature DB >> 22504250

A case of congenital dyserythropoietic anemia type 1 in a Japanese adult with a CDAN1 gene mutation and an inappropriately low serum hepcidin-25 level.

Hiroshi Kawabata1, Sayoko Doisaki, Akio Okamoto, Tatsuki Uchiyama, Soichiro Sakamoto, Asahito Hama, Kiminori Hosoda, Junji Fujikura, Hitoshi Kanno, Hisaichi Fujii, Naohisa Tomosugi, Kazuwa Nakao, Seiji Kojima, Akifumi Takaori-Kondo.   

Abstract

We describe the first case of genetically diagnosed congenital dyserythropoietic anemia (CDA) type 1 in a Japanese man. The patient had hemolytic anemia since he was a child, and he developed diabetes, hypogonadism, and liver dysfunction in his thirties, presumably from systemic iron overload. When he was 48 years old a diagnosis was finally made by genetic analysis that revealed a homozygous mutation of CDAN1 gene (Pro1129Leu). His serum hepcidin-25 level was inappropriately low. We conclude that physicians should be aware of the possibility of CDA in a patient with anemia and systemic iron overload at any age.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504250     DOI: 10.2169/internalmedicine.51.6978

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

Review 1.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

2.  Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.

Authors:  Jessica A Meznarich; Lauren Draper; Robert D Christensen; Hassan M Yaish; Nick D Luem; Theodore J Pysher; Grace Jung; Elizabeta Nemeth; Tomas Ganz; Diane M Ward
Journal:  Blood Cells Mol Dis       Date:  2018-03-20       Impact factor: 3.039

3.  Congenital dyserythropoietic anemia type 1 with a novel mutation in the CDAN1 gene previously diagnosed as congenital hemolytic anemia.

Authors:  Hisanori Fujino; Sayoko Doisaki; Young-Dong Park; Asahito Hama; Hideki Muramatsu; Seiji Kojima; Shinichi Sumimoto
Journal:  Int J Hematol       Date:  2013-04-19       Impact factor: 2.490

4.  The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.

Authors:  Tatsuki Uchiyama; Hiroshi Kawabata; Yasuo Miura; Satoshi Yoshioka; Masaki Iwasa; Hisayuki Yao; Soichiro Sakamoto; Masakazu Fujimoto; Hironori Haga; Norimitsu Kadowaki; Taira Maekawa; Akifumi Takaori-Kondo
Journal:  Cancer Med       Date:  2015-08-15       Impact factor: 4.452

5.  Congenital dyserythropoiesis anemia type Ia with a novel CDAN1 mutation diagnosed by whole exome sequencing.

Authors:  Pei-Chin Lin; Chao-Neng Cheng; Hsi-Yuan Huang; Yu-Hsin Tseng; Ya-Sian Chang; Chien-Yu Lin; Jan-Gowth Chang
Journal:  Mol Genet Genomic Med       Date:  2020-03-11       Impact factor: 2.183

Review 6.  The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.

Authors:  Noémi B A Roy; Christian Babbs
Journal:  Br J Haematol       Date:  2019-03-05       Impact factor: 6.998

Review 7.  Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.

Authors:  Achille Iolascon; Maria Rosaria Esposito; Roberta Russo
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.